Inovio Pharmaceuticals Inc Sustainability Reports
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines and vaccines. Its products and therapies are designed to treat and protect people from human papillomavirus (HPV) related diseases, cancer, and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900B9W875XDZXTM97
FIGI: BBG001S5RHZ0
5 reports from 2008 to 2023
